Yikes_老虎社区_美港股上老虎

2021-06-08

Yikes

Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":117941590,"tweetId":"117941590","gmtCreate":1623114899110,"gmtModify":1634036808872,"author":{"id":3581385014673304,"idStr":"3581385014673304","authorId":3581385014673304,"authorIdStr":"3581385014673304","name":"Qkuca","avatar":"https://static.tigerbbs.com/69a0785cbfa53d9d0452a1870c401782","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":26,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Yikes</p></body></html>","htmlText":"<html><head></head><body><p>Yikes</p></body></html>","text":"Yikes","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/117941590","repostId":1113342569,"repostType":4,"repost":{"id":"1113342569","pubTimestamp":1623114456,"share":"https://www.laohu8.com/m/news/1113342569?lang=&edition=full","pubTime":"2021-06-08 09:07","market":"us","language":"en","title":"Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113342569","media":"cnbc","summary":"Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's ap","content":"<div>\n<p>Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's approvalofBiogen's Alzheimer's disease drug, Aduhelm, saying \"the evidence to approve the drug wasn't ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/07/biogen-alzheimers-drug-dementia-expert-says-evidence-wasnt-sufficient-for-approval.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 09:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/07/biogen-alzheimers-drug-dementia-expert-says-evidence-wasnt-sufficient-for-approval.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's approvalofBiogen's Alzheimer's disease drug, Aduhelm, saying \"the evidence to approve the drug wasn't ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/07/biogen-alzheimers-drug-dementia-expert-says-evidence-wasnt-sufficient-for-approval.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.cnbc.com/2021/06/07/biogen-alzheimers-drug-dementia-expert-says-evidence-wasnt-sufficient-for-approval.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1113342569","content_text":"Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's approvalofBiogen's Alzheimer's disease drug, Aduhelm, saying \"the evidence to approve the drug wasn't sufficient.\"\"Another study is needed to establish whether this drug, in fact, is effective. Unfortunately, the FDA approved the drug for marketing, although they also do want another study,\" the co-director of the Penn Memory Center at the University of Pennsylvania said on Monday following the agency's formal OK.The FDA's approval marks thefirst new treatment for Alzheimer'sin nearly two decades. Alzheimer's is a progressive neurodegenerative disorder that slowly destroys memory and thinking skills. More than 6 million Americans live with the disease, according toestimates by the Alzheimer's Association.Karlawish told\"The News with Shepard Smith\"that there are a lot of promising Alzheimer's drugs in the pipeline.\"I'm optimistic about the coming future here, so I have hope. I just think this is not the drug upon which to pin our hopes,\" he said. \"Desperation should drive funding for Alzheimer's research, it should not drive the interpretation of scientific evidence.\"Clinical trials found some patients who got the approved dose of Aduhelm experienced painful brain swelling.\"What you're asking someone to do, is to take a chance at uncertain benefit, but known risk,\" Karlawish said of prescribing the drug to patients.The FDA said it will continue to monitor the drug as it reaches the U.S. market. The agency granted approval on the condition that Biogen conduct another clinical trial.Karlawish told host Shepard Smith that Biogen will face a challenge in \"how to do that study when the drug is also available for clinical prescribing.\"Representatives for Biogen and for the FDA did not immediately return requests for comment on Karlawish's statements.","news_type":1},"isVote":1,"tweetType":1,"viewCount":68,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/117941590"}